JMKX000623
JMKX0623-201
Phase 2 small_molecule active
Quick answer
JMKX000623 for Diabetic Peripheral Neuropathic Pain is a Phase 2 program (small_molecule) at Jemincare with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jemincare
- Indication
- Diabetic Peripheral Neuropathic Pain
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active